Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
+559K
-
Total reported value, excl. options
-
$616M
-
Value change
-
+$22.6M
-
Number of buys
-
73
-
Number of sells
-
-59
-
Price
-
$38.74
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q3 2018
164 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q3 2018.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 22.7M outstanding shares and own 70.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.55M shares), Conestoga Capital Advisors, LLC (1.61M shares), Vanguard Group Inc (1.21M shares), DIMENSIONAL FUND ADVISORS LP (1.02M shares), Epoch Investment Partners, Inc. (834K shares), Ranger Investment Management, L.P. (723K shares), JANUS HENDERSON GROUP PLC (691K shares), STATE STREET CORP (649K shares), THOMSON HORSTMANN & BRYANT INC (396K shares), and AMERIPRISE FINANCIAL INC (373K shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.